An examination of the evidence supporting the association of dietary cholesterol and saturated fats with serum cholesterol and development of coronary heart disease

Alternative Medicine Review

Volumn 12, Issue 3, 2007, Pages 228-245

  Volk, Marion G ^a,b  

^a CHARLES STURT UNIVERSITY   (Australia)

^b Cambridge Health Centre   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; MONOUNSATURATED FATTY ACID; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID;

CHOLESTEROL BLOOD LEVEL; CHOLESTEROL INTAKE; CORRELATION ANALYSIS; DRUG EFFECT; DRUG MECHANISM; EVIDENCE BASED MEDICINE; FAT INTAKE; HUMAN; HYPOTHESIS; ISCHEMIC HEART DISEASE; LIPID HYPOTHESIS; METHODOLOGY; MORBIDITY; MORTALITY; NUTRITIONAL ASSESSMENT; PATHOLOGY; PATHOPHYSIOLOGY; RESEARCH; REVIEW; RISK FACTOR; TREATMENT PLANNING;

ANIMALS; CAUSE OF DEATH; CHOLESTEROL, DIETARY; CORONARY DISEASE; DIETARY FATS; EVIDENCE-BASED MEDICINE; FOLLOW-UP STUDIES; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 35348954285     PISSN: 10895159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (77)

1. Haiton TL, Willett WC, Liu S, et al. Potato and french fry consumption and risk of type 2 diabetes in women. Am J Clin Nutr 2006;83:284-290.
2. Daly ME, Paisey R, Paisey R, et al, Short-term effects of severe dietary carbohydrate-restriction advice in type 2 diabetes - a randomized controlled trial. Diabet Med 2006;23:15-20.
3. Musick T, Cymet TC. Carbohydrate and calories: it is not what we used to think. Compr Ther 2006;32:47-50.
4. Pins JJ, Keenan JM. Dietary and nutraceutical options for managing the hypertriglyceridemic patient. Prog Cardiovasc Nurs 2006;21:89-93.
5. Mozaffarian D. Effects of dietary fats versus carbohydrates on coronary heart disease: a review of the evidence. Curr Atheroscler Rep 2005;7:435-445.
6. McCully KS. Atherosclerosis, serum cholesterol and the homocysteine theory: a study of 194 consecutive autopsies. Am J Med Sci 1990;299:217-221.
7. Keys A. Atherosclerosis: a problem in newer public health. J Mt Sinai Hosp N Y 1953;20:118-139.
8. Steinberg D, The cholesterol controversy is over. Why did it take so long? Circulation 1989;80:1070-1078.
9. Rosenman RH, The independent roles of diet and serum lipids in the 20th-century rise and decline of coronary heart disease mortality. Integr Physiol Behav Sci 1993;28:84-98.
10. Hu FB, Stampfer MJ, Manson JE, et al. Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med 1997;337:1491-1499.
11. Hooper L, Summerbell CD, Higgins JP, et al. Reduced or modified dietary fat for preventing cardiovascular disease. Cochrane Database Syst Rev 2001;(3):CD002137.
12. Stehbens WE. The hypothetical epidemic of coronary heart disease and atherosclerosis. Med Hypotheses 1995;45:449-454.
13. Lozano R, Murray CJL, Lopez AD, Satoh T. Miscoding and misclassification of ischaemic heart disease mortality. Global Programme of Evidence for Health Policy Working Paper No 12. WHO 2001. http://www. who.int/healthinfo/paper12. pdf. [Accessed April 21, 2006]
14. Kuhn TS. The Structure of Scientific Revolutions, Chicago, IL: The University of Chicago Press; 1970.
15. Ravnskov U. Quotation bias in reviews of the diet-heart idea. J Clin Epidemiol 1995;48:713-719.
16. Keys A. Coronary heart disease in seven countries. 1970. Nutrition 1997;13:250-252.
17. Anderson KM, Castelli WP, Levy D. Cholesterol and mortality. 30 years of follow-up from the Framingham study. JAMA 1987;257:2176-2180.
18. No authors listed. Multiple Risk Factor Intervention Trial. Risk factor changes and mortality results. Multiple Risk Factor Intervention Trial Research Group. JAMA 1982;248:1465-1477.
19. http://www3.interscience.wiley.com/ cgi-bin/mrwhome/106568753/ HOME?CRETRY=1&SRETRY=0 [Accessed July 27, 2007]
20. http://www.cebm.net/levels_of_evidence.asp [Accessed March 15, 2006]
21. Robertson TL, Kato H, Rhoads GG, et al. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California. Incidence of myocardial infarction and death from coronary heart disease. Am J Cardiol 1977;39:239-243.
22. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, et al. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 1994;90:583-612.
23. Dawber TR, Kannel WB. Coronary heart disease as an epidemiology entity. Am J Public Health Nations Health 1963;53:433-437.
24. Shekelle RB, Shryock AM, Paul O, et al. Diet, serum cholesterol, and death from coronary heart disease. The Western Electric Study. N Engl J Med 1981;304:65-70.
25. Carman WJ, Barrett-Connor E, Sowers M, Khaw KT. Higher risk of cardiovascular mortality among lean hypertensive individuals in Tecumseh, Michigan. Circulation 1994;89:703-711.
26. Nichols AB, Ravenscroft C, Lamphiear DE, Ostrander LD Jr. Daily nutritional intake and serum lipid levels. The Tecumseh Study. Am J Clin Nutr 1976;29:1384-1392.
27. Kromhout D, de Lezenne Coulander C. Diet, prevalence and 10-year mortality from coronary heart disease in 871 middle-aged men. The Zutphen Study. Am J Epidemiol 1984;119:733-741.
28. Goldbourt U, Yaari S. Cholesterol and coronary heart disease mortality. A 23-year follow-up study of 9902 men in Israel. Arteriosclerosis 1990;10:512-519.
29. Yano K, Reed DM, McGee DL. Ten-year incidence of coronary heart disease in the Honolulu Heart Program. Relationship to biologic and lifestyle characteristics. Am J Epidemiol 1984;119:653-666.
30. McGee DL, Reed DM, Yano K, et al. Ten-year incidence of coronary heart disease in the Honolulu Heart Program. Relationship to nutrient intake. Am J Epidemiol 1984;119:667-676.
31. Garcia-Palmieri MR, Feliberti M, Costas RJr, et al. An epidemiological study on coronary heart disease in Puerto Rico: The Puerto Rico Heart Health Program. Bol Asoc Med P R 1969;61:174-179.
32. Fuller JH, Shipley MJ, Rose G, et al. Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study. Br Med J (Clin Res Ed) 1983;287:867-870.
33. Castelli WP, Doyle JT, Gordon T, et al. HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study. Circulation 1977;55:767-772.
34. Willett WC, Stampfer MJ, Manson JE, et al. Intake of trans fatty acids and risk of coronary heart disease among women. Lancet 1993;341:581-585.
35. Cornoni-Huntley J, Ostfeld AM, Taylor JO, et al. Established populations for epidemiologic studies of the elderly: study design and methodology. Aging (Milano) 1993;5:27-37.
36. Olson RE. Discovery of the lipoproteins, their role in fat transport and their significance as risk factors. J Nutr 1998;128:439S-443S.
37. Pocock SJ, Collier TJ, Dandreo KJ, et al. Issues in the reporting of epidemiological studies: a survey of recent practice. BMJ 2004;329:883.
38. Chan AW, Altman DG. Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authors. BMJ 2005;330:753.
39. Gotzsche PC. Believability of relative risks and odds ratios in abstracts: cross sectional study. BMJ 2006;333:231-234.
40. Leitner ZA. Diet and coronary disease. Med World 1954;81:249-254.
41. Keys A, Anderson JT. Symposium on Atherosclerosis. National Research Council Publication 338: 1955.
42. Yerushalmy J, Hilleboe HE. Fat in the diet and mortality from heart disease; a methodologic note. N Y State J Med 1957;57:2343-2354.
43. Keys A, Menotti A, Aravanis C, et al. The Seven Countries Study: 2,289 deaths in 15 years. Prev Med 1984;13:141-154.
44. Menotti A, Blackburn H, Kromhout D, et al. Changes in population cholesterol levels and coronary heart disease deaths in seven countries. Eur Heart J 1997;18:566-571.
45. Epstein FH. Cardiovascular disease epidemiology: a journey from the past into the future. Circulation 1996;93:1755-1764.
46. Keys A, Anderson JT, Grande F. Serum cholesterol response to changes in the diet, IV: particular fatty acids in the diet. Metabolism 1965;14:776-787.
47. Wilson PW, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-1847.
48. Dawber TR, Meadors GF, Moore FE. Epidemiological approaches to heart disease: the Framingham study. Am J Public Health Nations Health 1951;41:279-281.
49. Grundy SM, Balady GJ, Criqui MH, et al. Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association. Circulation 1998;97:1876-1887.
50. D'Agostino RB Sr, Grundy S, Sullivan LM, et al. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 2001;286:180-187.
51. Thomsen TF, McGee D, Davidsen M, Jorgensen T. A cross-validation of risk scores for coronary heart disease mortality based on data from the Glostrup Population Studies and Framingham Heart Study. Int J Epidemiol 2002;31:817-822.
52. Haq IU, Ramsay LE, Yeo WW, et al. Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men. Heart 1999;81:40-46.
53. Brindle PM, McConnachie A, Upton MN, et al. The accuracy of the Framingham risk-score in different socioeconomic groups: a prospective study. Br J Gen Pract 2005;55:838-845.
54. Kuller L, Neaton J, Caggiula A, Falvo-Gerard L. Primary prevention of heart attacks: the multiple risk factor intervention trial. Am J Epidemiol 1980;112:185-199.
55. Neaton JD, Grimm RH Jr, Cutler JA. Recruitment of participants for the Multiple Risk Factor Intervention Trial (MRFIT). Control Clin Trials 1987;8:41S-53S.
56. Wentworth DN, Neaton JD, Rasmussen WL. An evaluation of the Social Security Administration master beneficiary record file and the National Death Index in the ascertainment of vital status. Am J Public Health 1983;73:1270-1274.
57. Stamler J, Wentworth D, Neaton JD. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 1986;256:2823-2828.
58. MacMahon SW, Cutler JA, Neaton JD, et al. Relationship of blood pressure to coronary and stroke morbidity and mortality in clinical trials and epidemiological studies. J Hypertens Suppl 1986;4:S14-S17.
59. Neaton JD, Wentworth D. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group. Arch Intern Med 1992;152:56-64.
60. Lauer MS, Blackstone EH, Young JB, Topol EJ. Cause of death in clinical research: time for a reassessment? J Am Coll Cardiol 1999;34:618-620.
61. ICD = International Classification of Diseases published by the World Health Organization (WHO).
62. Tarasuk VS, Brooker AS. Interpreting epidemiologic studies of diet-disease relationships. J Nutr 1997;127:1847-1852.
63. Freudenheim JL. Study design and hypothesis testing: issues in the evaluation of evidence from research in nutritional epidemiology. Am J Clin Nutr 1999;69:1315S-1321S.
64. Stanton RA. Nutrition problems in an obesogenic environment. Med J Aust 2006;184:76-79.
65. Felton CV, Crook D, Davies MJ, Oliver MF. Dietary polyunsaturated fatty acids and composition of human aortic plaques. Lancet 1994;344:1195-1196.
66. Marmot MG, Syme SL, Kagan A, et al. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: prevalence of coronary and hypertensive heart disease and associated risk factors. Am J Epidemiol 1975;102:514-525.
67. Wannamethee SG, Shaper AG, Lennon L, Morris RW. Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med 2005;165:2644-2650.
68. Willett WC. Dietary fat and obesity: an unconvincing relation. Am J Clin Nutr 1998;68:1149-1150.
69. Ravnskov U. Cholesterol lowering trials in coronary heart disease: frequency of citation and outcome. BMJ 1992;305:15-19.
70. Stehbens WE. Coronary heart disease, hypercholesterolemia, and atherosclerosis. II. Misrepresented data. Exp Mol Pathol 2001;70:120-139.
71. Klevay LM. Ischemic heart disease as deficiency disease. Cell Mol Biol (Noisy-le-grand) 2004;50:877-884.
72. Blanco-Colio LM, Tunon J, Martin-Ventura JL, Egido J. Anti-inflammatory and immunomodulatory effects of statins. Kidney Int 2003;63:12-23.
73. Varughese GI, Patel JV, Lip GY, Varma C. Novel concepts of statin therapy for cardiovascular risk reduction in hypertension. Curr Pharm Des 2006;12:1593-1609.
74. Grimes DS. Are statins analogues of vitamin D? Lancet 2006;368:83-86.
75. Eaton SB, Eaton SB. Paleolithic vs. modern diets - selected pathophysiological implications. Eur J Nutr 2000;39:67-70.
76. Cordain L, Miller JB, Eaton SB, Mann N. Macronutrient estimations in hunter-gatherer diets. Am J Clin Nutr 2000;72:1589-1592.
77. Cordain L, Eaton SB, Miller JB, et al. The paradoxical nature of hunter-gatherer diets: meat-based, yet non-atherogenic. Eur J Clin Nutr 2002;56:S42-S52.